{
  "ptid_time": "068_S_2184_2019-11-21",
  "img_path": "/data/qiuhui/data/adni/images/068_S_2184/2019-11-21/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 31,111 mm³, 15.8% below the reference mean. With a Z-score of -0.43 (33.5th percentile), this represents normal volume ; hippocampal volume measures 6,716 mm³, 3.4% above the reference mean. With a Z-score of 0.27 (60.7th percentile), this represents normal volume ; whole brain volume measures 1,005,720 mm³, 8.4% above the reference mean. With a Z-score of 1.00 (84.2th percentile), this represents mild enlargement; entorhinal cortex volume measures 5,040 mm³, 45.6% above the reference mean. With a Z-score of 2.46 (99.3th percentile), this represents significant enlargement; fusiform gyrus volume measures 15,441 mm³, 4.2% below the reference mean. With a Z-score of -0.31 (37.8th percentile), this represents normal volume ; middle temporal gyrus volume measures 18,428 mm³, 2.2% above the reference mean. With a Z-score of 0.20 (57.8th percentile), this represents normal volume . ",
  "text_data": "Age is 89.4 years. Gender is Female. Education: 16 years. MMSE: 29.0. MoCA: 28.0. Logical Memory: 15.0. APOEε4 alleles: 1.0. Biomarker levels: Florbetapir (AV45): 1.73 SUVR (profound elevated). ",
  "true_diagnosis": "Diagnosis: CN.",
  "gpt_diagnosis": "**Reasoning:** The brain volume measurements show normal or above-normal volumes in key regions (hippocampus, entorhinal cortex, whole brain), with no significant atrophy typically seen in Alzheimer's. Cognitive scores (MMSE 29, MoCA 28) are intact, but the profound AV45 (amyloid) elevation suggests amyloid pathology. APOE4 carrier status increases Alzheimer's risk, but the lack of structural or cognitive decline argues against dementia.  \n**Diagnosis:** **CN (Cognitively Normal)** with amyloid pathology (preclinical Alzheimer's).  \n**Confidence:** **Medium** (high amyloid burden is concerning, but preserved structure/function supports current normality).  \n\n*Note: This individual may be in the preclinical stage of Alzheimer's due to amyloid positivity, but they do not meet criteria for MCI or dementia at this time.*",
  "timestamp": "2025-07-26T08:54:25.626900"
}